mitral

Terapia endovascular en stroke: mucha evidencia y pocos operadores entrenados

SOLACI-SOCIME 2018 | New Indications

Read articles on the main presentations of the first day of SOLACI-SOCIME 2018 Congress. See the presentation by Dr. Flavio Ribichini, entitled “New Indications”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

Casos en vivo, editados y simposios patrocinados

Live Cases, Edited Cases and Lunch Symposiums Sponsored by the Industry

The participation of the medical industry is, undoubtedly, one of the most appealing aspects of the SOLACI-SOCIME 2018 Congress. As usual, the most important companies in this industry have decided to take part in our event. Their contribution is most valuable, as it brings relevance and improves the quality of our scientific presentations. Organize your...

MitraClip frecuencia ritmo cardíaco

MitraClip in Severe MR: 5 Year Mortality Rate Similar to Surgery

Courtesy of Dr. Carlos Fava. Mitral regurgitation accounts for around 25% of valvular diseases and is a strong mortality predictor in heart disease. One of the challenges of this disease is that patients respond favorably to medical treatment for a long time, which makes hard to establish the right time to perform an intervention without...

Terapia endovascular en stroke: mucha evidencia y pocos operadores entrenados

Endovascular Therapy in Stroke: Much Evidence and Few Trained Operators

Endovascular therapy is now considered as the standard of care for acute ischemic stroke caused by large vessel occlusion. The time between symptoms onset and reperfusion emerges as the most determinant factor for good clinical outcomes, much more strongly than even in acute myocardial infarction. The saying “time is brain” is even more relevant than...

DES de 2.0 mm para vasos muy pequeños: ¿Es viable?

New Ultra-Thin-Strut DES: Do They Outperform Second-Generation DES?

The new drug-eluting stents (DES) equipped with ultra-thin struts are showing a lower risk of target lesion failure as a result of lower rates of acute myocardial infarction and similar rates of revascularization, according to this meta-analysis soon to be published in Circulation. Such a difference is evidenced at a 1-year follow-up when compared with...

Over 10 Keynote Conferences Confirmed at SOLACI-SOCIME 2018 Congress

We are less than a month away from the most important interventional cardiology event in Latin America. Consequently, we have started to share information on some of the most appealing sessions that you will be able to enjoy in Mexico City from August 1st to 3rd, 2018. On that vein, we are pleased to communicate...

Tarjeton-Jornadas-Guatemala-2018

See the presentations of the 2018 Guatemala Sessions

SOLACI thanks the 210 attendees ─physicians, nurses, technicians and other professionals. Without them, we would not have achieved such scientific success at these regional sessions. We would also like to extend our appreciation to the Guatemalan Cardiology Association, to the organization, and to the entire Guatemala for the hospitality and generosity they graciously bestowed upon...

La reparación de la válvula mitral con Mitraclip es segura en pacientes de alto riesgo

Tricuspid Regurgitation: MitraClip Improves Survival

Courtesy of Dr. Carlos Fava. Tricuspid regurgitation (TR), both isolated or associated with other left valve diseases, has been associated with higher rates of heart failure hospitalization and of cardiovascular death. Recent studies in elderly high-risk patients who underwent percutaneous treatment of left valve disease have shown the presence of TR to be associated with...

Top